Genmab · 2 weeks ago
Statistical Programming Intern
Princeton, NJ
Internship
Hybrid
Intern
Start in 2026 SummerGenmab is an international biotechnology company focused on improving patients' lives through innovative antibody therapeutics. The Statistical Programming Internship offers students hands-on experience in drug development, involving clinical research programming and collaboration across functions to support data analysis and visualization.
BiotechnologyHealth CareManufacturingMedical
No H1B
Responsibilities
Gain hands-on experience with programming tools including SAS, R, and Python
Support the production of analysis datasets, tables, figures, and listings by writing, testing, and validating corresponding programs
Develop data visualizations or tools to streamline and automate programming tasks
Learn industry standards, best practices, and regulatory requirements for Clinical and Statistical Programming
Support reporting and visualization of clinical trial data
Gain familiarity with computing environments, applications, and tools used in Clinical and Statistical Programming
Participate in weekly mentorship meetings with programming and team leads
Engage in networking and cross-functional collaboration with teams such as Biostatistics and Data Management
Complete a project based on a real Programming assignment (e.g., automation of data package checks for FDA submissions or testing standard code libraries)
Present the completed project to the Extended Programming Leadership Team and other stakeholders, demonstrating skills, insights, and potential for future full-time opportunities
Qualification
Required
Students in their second year of a Master's degree in Statistics, Mathematics, Computer Science, Bioinformatics, Data Science or related fields. (Expected Graduation: December 2026 or May 2027)
Interest in clinical research
Basic understanding of Clinical and/or Statistical Programming
Academic experience with relevant programming languages (e.g. SAS, R, Python)
Preferred
Advanced experience with relevant programming languages (e.g. SAS, R, Python)
Company
Genmab
Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer.
Founded in 1999
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
$11.7BKey Investors
Morgan Stanley Senior FundingGlaxoSmithKlineIndex Ventures
2025-11-18Post Ipo Debt· $6B
2025-09-29Post Ipo Debt· $5.5B
2010-07-01Post Ipo Equity· $134M
Leadership Team
Anthony Pagano
Chief Financial Officer
Anthony Mancini
EVP & Chief Operating Officer
Recent News
2026-01-20
2026-01-19
2026-01-19
Company data provided by crunchbase